Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder
Shani Poleg, Emad Kourieh, Angela Ruban, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics
Junbin Tian, Xuping Gao, Li Yang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 60
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 44
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors
Antonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
Pharmacological Research (2024) Vol. 203, pp. 107176-107176
Open Access | Times Cited: 8
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran, Dalit Cayam Rand
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 65-79
Closed Access | Times Cited: 6
Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease
Kamila Gabrieli Dallabrida, Jeane Maria de Oliveira, Ellen Schavarski Chade, et al.
Brain Sciences (2024) Vol. 14, Iss. 6, pp. 592-592
Open Access | Times Cited: 6
Efficacy and Safety of Cannabinoids for Autism Spectrum Disorder: An Updated Systematic Review
Danilo Assis Pereira, Lídia Cheidde, Mateus Daniel R Megiolaro, et al.
Cureus (2025)
Open Access
Targeting Shank3 deficiency and paresthesia in autism spectrum disorder: A brief review
Min Huang, Qi Qi, Tao Xu
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 8
Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial
Vered Hermush, Liora Ore, Noa Stern, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Hyperbaric Oxygen Therapy Alleviates Social Behavior Dysfunction and Neuroinflammation in a Mouse Model for Autism Spectrum Disorders
Inbar Fischer, Sophie Shohat, Gilad Levy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11077-11077
Open Access | Times Cited: 10
Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium
Valentin Ioannidis, Rakshita Pandey, Helen Friedericke Bauer, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 3, pp. 704-717
Open Access | Times Cited: 6
The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
Roberto Coccurello, Maria Cristina Marrone, Mauro Maccarrone
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Pathophysiology of the endocannabinoid system in Autism Spectrum Disorder: A Narrative Review
Andrey Alves Siqueira de Miranda, Carla Caroline Vieira e Silva, Marcus Vinícius de Alencar Barbosa, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 19, pp. 2-11
Open Access
A EFICÁCIA DO TRATAMENTO COM CANABIDIOL NO TRANSTORNO DO ESPECTRO AUTISTA: UMA REVISÃO NARRATIVA DA LITERATURA
Ana Angélica Ferreira Bento Cardoso Leão, M. Gomes, Douglas Roberto Guimarães Silva
Revista Contemporânea (2024) Vol. 4, Iss. 10, pp. e6249-e6249
Open Access
The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder
Maína Pereira Bonetti, Elisa Borsani, Francesca Bonomini
Cells (2024) Vol. 13, Iss. 24, pp. 2036-2036
Open Access
Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study
Micha Hacohen, Orit Stolar, Matitiahu Berkovitch, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
O USO DE CANNABIS MEDICINAL NO TRANSTORNO DO ESPECTRO AUTISTA: UMA NOVA TERAPÊUTICA VIÁVEL?
Larissa Ciarlini Varandas Sales, Guilherme Alvez Ferreira da Cruz, Tatiana Paschoalette Rodrigues Bachur
Revista Intertox de Toxicologia Risco Ambiental e Sociedade (2023) Vol. 16, Iss. 1, pp. 48-62
Open Access
Pharmacotherapeutic effects of cannabidiol in autism spectrum disorders
Michael David Parkhill
(2023)
Open Access
Canabinoides: aspectos histórico-culturais, químicos e farmacológicos
Fabio Batista da Costa, Antônia Maria das Graças Lopes Citó, Danielle da Costa Silva
(2023)
Open Access
Spotted around the web: Antipsychotic prescriptions, global autism prevalence, mouse genetic drift
Jill Adams
The Transmitter (2021)
Open Access
Page 1

Scroll to top